Abstract
Ischemia-reperfusion (I/R) injury is a complex process involving the generation and release of inflammatory cytokines, and the accumulation and infiltration of neutrophils and macrophages, which disturbs the microcirculatory hemodynamics. Nonetheless, ischemic preconditioning (IPC) is known to produce immediate tolerance to subsequent prolonged I/R insults, although its underlying mechanism largely remains unknown. Our study investigated the role of the IκB-α-NF-κB-TNF-α (tumor necrosis factor-α) pathway in IPC's ability to ameliorate I/R-induced microcirculatory disturbances in rat cremaster muscle flaps. Male Sprague-Dawley rats were randomized (n=8 per group) into 3 groups: a sham-operated control group, an I/R group (4 h of pudic epigastric artery ischemia followed by 2 h of reperfusion), and an IPC+I/R group (3 cycles of 10 min of ischemia followed by 10 min reperfusion before I/R). Intravital microscopy was used to observe leukocyte/endothelial cell interactions and quantify functional capillaries in cremaster muscles. I/R markedly increased the number of rolling, adhering, and migrating leukocytes. It was also observed that I/R significantly increased TNF-α expression in these injured tissues. On the other hand, IPC prevented I/R-induced increases in leukocyte rolling, adhesion, and transmigration. Moreover, TNF-α protein production and its mRNA expression were downregulated in the IPC group. Finally, I/R-induced IκB-α phosphorylation and NF-κB (p65) nuclear translocation were both suppressed by IPC. These results indicated that IPC attenuated NF-κB activation and subsequently reduced TNF-α expression, which resulted in the amelioration of microcirculatory disturbances in I/R-injured cremaster muscles.
Similar content being viewed by others
References
Adanali G, Ozer K, Siemionow M. Early and late effects of ischemic preconditioning on microcirculation of skeletal muscle flaps. Plast Reconstr Surg 109:1344–1351;2002.
Akimitsu T, Gute DC, Korthuis RJ. Ischemic preconditioning attenuates postischemic leukocyte adhesion and emigration. Am J Physiol 271:H2052–2059;1996.
Azzawi M, Hasleton P. Tumor necrosis factor alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease. Cardiovasc Res 43:850–859;1999.
Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 5:384–394;1973.
Banerjee A, Locke Winter C, Rogers KB, Mitchell MB, Brew EC, Cairns CB, Bensard DD, Harken AH. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism. Circ Res 73:656–670;1993.
Baxter GF, Ebrahim Z. Role of bradykinin in preconditioning and protection of the ischaemic myocardium. Br J Pharmacol 135:843–854;2002.
Carden DL, Granger DN. Pathophysiology of ischaemia reperfusion injury. J Pathol 190:255–266;2000.
Cepinskas G, Rui T, Kvietys PR. Neutrophilendothelial cell interactions during the development of tolerance to ischaemia/reperfusion in isolated cells. Acta Physiol Scand 173:23–33;2001.
Chen W, Gabel S, Steenbergen C, Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res 77:424–429;1995.
Chensue SW, Remick DG, Shmyr-Forsch C, Beals TF, Kunkel SL. Immunohistochemical demonstration of cytoplasmic and membrane associated TNF in murine macrophages. Am J Pathol 133:564–572;1988.
Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85:1936–1943;1990.
Crinnion JN, Homer-Vanniasinkam S, Gough MJ. Skeletal muscle reperfusion injury: pathophysiology and clinical considerations. Cardiovasc Surg 1:317–324;1993.
Cutrn JC, Perrelli MG, Cavalieri B, Peralta C, Rosell Catafau J, Poli G. Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic Biol Med 33:1200–1208;2002.
Dayton C, Yamaguchi T, Warren A, Korthuis RJ. Ischemic preconditioning prevents postischemic arteriolar, capillary, and postcapillary venular dysfunction: signaling pathways mediating the adaptive metamorphosis to a protected phenotype in preconditioned endothelium. Microcirculation 9:73–89;2002.
Donnahoo KK, Shames BD, Harken AH, Meldrum DR. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 162:196–203;1999.
Ferdinandy P, Szilvassy Z, Balogh N, Csonka C, Csont T, Koltai M, Dux L. Nitric oxide is involved in active preconditioning in isolated working rat hearts. Ann NY Acad Sci 793:489–493;1996.
Glazier SS, O'Rourke DM, Graham DL, Welsh FA. Induction of ischemic tolerance following brief focal ischemia in rat brain. J Cereb Blood Flow Metab 14:545–553;1994.
Hiasa G, Hamada M, Ikeda S, Hiwada K. Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-κB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart. Jpn Circ J 65:984–990;2001.
Hoshida S, Kuzuya T, Nishida M, Yamashita N, Oe H, Hori M, Kamada T, Tada M. Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts. Cardiovasc Res 28:1083–1088;1994.
Hotter G, Closa D, Prados M, Fernandez-Cruz L, Prats N, Gelpi E, Rosello-Catafau J. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun 222:27–32;1996.
Ikeda U, Ikeda M, Kano S, Shimada K. Neutrophil adherence to rat cardiac myocyte by proinflammatory cytokines. J Cardiovasc Pharmacol 23:647–652;1994.
Jerome SN, Akimitsu T, Gute DC, Korthuis RJ. Ischemic preconditioning attenuates capillary noreflow induced by prolonged ischemia and reperfusion. Am J Physiol 268:H2063–2067;1995.
Krishnadasan B, Naidu BV, Byrne K, Fraga C, Verrier ED, Mulligan MS. The role of proinflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 125:261–272;2003.
Kubes P, Payne D, Ostrovsky L. Preconditioning and adenosine in I/R-induced leukocyte-endothelial cell interactions. Am J Physiol 274:H1230–1238;1998.
Kupatt C, Habazettl H, Goedecke A, Wolf DA, Zahler S, Boekstegers P, Kelly RA, Becker BF. Tumor necrosis factor-α contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts. Circ Res 84:392–400;1999.
Li S, Sedivy JM. Raf-1 protein kinase activates the NFκB transcription factor by dissociating the cytoplasmic NFκB-IκB complex. Proc Natl Acad Sci USA 90:9247–9251;1993.
Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 27:883–892;1995.
Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol 274:R577–595;1998.
Morgan EN, Boyle EM Jr, Yun W, Griscavage-Ennis JM, Farr AL, Canty TG Jr, Pohlman TH, Verrier ED. An essential role for NF-κB in the cardioadaptive response to ischemia. Ann Thorac Surg 68:377–382;1999.
Murry C, Jenning R, Reimer K. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136;1986.
Pang CY, Yang RZ, Zhong A, Xu N, Boyd B, Forrest CR. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res 29:782–788;1995.
Peralta C, Closa D, Hotter G, Gelpi E, Prats N, Rosello-Catafau J. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun 229:264–270;1996.
Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 25:934–937;1997.
Peralta C, Hotter G, Closa D, Prats N, Xaus C, Gelpi E, Rosello-Catafau J. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 29:126–132;1999.
Rahman I, MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax 53:601–612;1998.
Ricciardi R, Shah SA, Wheeler SM, Quarfordt SH, Callery MP, Meyers WC, Chari RS. Regulation of NFkappaB in hepatic ischemic preconditioning. J Am Coll Surg 195:319–326;2002.
Richard V, Kaeffer N, Tron C, Thuillez C. Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation 89:1254–1261;1994.
Sayers TJ, Wiltrout TA, Bull CA, Denn AC 3rd, Pilaro AM, Lokesh B. Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. Prostaglandin and leukotriene-independent induction of infiltration by IL-1 and tumor necrosis factor. J Immunol 141:1670–1677;1988.
Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor-alpha gene in primary macrophages. J Exp Med 171:35–47;1990.
Squadrito F, Altavilla D, Zingarelli B, Ioculano M, Calapai G, Campo GM, Miceli A, Caputi AP. Tumor necrosis factor involvement in myocardial ischaemia-reperfusion injury. Eur J Pharmacol 237:223–230;1993.
Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38:307–314;2001.
Yaguchi Y, Satoh H, Wakahara N, Katoh H, Uehara A, Terada H, Fujise Y, Hayashi H. Protective effects of hydrogen peroxide against ischemia/reperfusion injury in perfused rat hearts. Circ J 67:253–258;2003.
Yao Z, Gross GJ. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol 264:H2221–2225;1993.
Yellon DM, Baxter GF, Garcia-Dorado D, Heusch G, Sumeray MS. Ischaemic preconditioning: Present position and future directions. Cardiovasc Res 37:21–33;1998.
Yin DP, Sankary HN, Chong AS, Ma LL, Shen J, Foster P, Williams JW. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 66:152–157;1998.
Zhou X, Zhai X, Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation 93:1177–1184;1996.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hung, LM., Wei, W., Hsueh, YJ. et al. Ischemic preconditioning ameliorates microcirculatory disturbance through downregulation of TNF-alpha production in a rat cremaster muscle model. J Biomed Sci 11, 773–780 (2004). https://doi.org/10.1007/BF02254362
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02254362